BME Launches The Hammerlock ® 2 Intramedullary Nitinol Fixation System Designed For Hammertoe Deformities

SAN ANTONIO, Nov. 3, 2014 /PRNewswire/ -- BioMedical Enterprises (BME) announced today the launch of the HammerLock^® 2 Intramedullary Nitinol Fixation System.  This is the long-awaited next generation of the popular HammerLock implant with innovative Nitinol technology—designed to provide surgeons with an intramedullary implant that does not require freezing.  This significant advancement allows surgeons to take advantage of the compressive benefits of Nitinol fixation while simplifying the logistics inside the operating room.

The new HammerLock 2 is an effective solution for hammertoe fixation.  It is designed to fit a wider range of anatomies, and with many points of stabilization within the toe, preventing rotation.  Most importantly, the HammerLock 2 system, like the patented BME Speed Fixation System, comes in pre-sterilized, fully disposable implant and instrument kits that enhance efficiencies in the operating room.  This patent-pending implant and system represent BME's commitment to developing, manufacturing and marketing the best solutions possible for institutions, surgeons and patients. 

Dr. Mark Myerson, Medical Director, The Institute for Foot and Ankle Reconstruction, Mercy Medical Center in Baltimore, MD stated, "I have used numerous intramedullary devices for stabilization of the proximal interphalangeal joint and the HL2 is by far the most predictable, versatile and reliable in my hands".

"Our ability to innovate at this level is made possible by a company-wide team effort that includes a group of distinguished surgeon advisors, dedicated engineers and tireless manufacturing team that design, develop, prototype and test exciting new ideas on a daily basis.  This process has allowed BME to become the premier company for shape memory fixation systems.  We are all excited about the opportunity that HL2 presents and for the prospects for 2015." said Keith M. Peeples, President and CEO of BME. 

The new BME HammerLock 2 Intramedullary Nitinol Fixation System is available now for commercial use throughout the United States.   

To learn more about BME's new HammerLock 2 System, visit www.bme-tx.com or call 800-880-6528.

About BME, Inc.

BME, Inc. is a privately-held leader in orthopedic shape memory implant technology for small bone fixation and the only U.S. manufacturer of Nitinol metal implants for musculoskeletal and soft tissue fixation. 

For over a decade, BME has spearheaded the innovation of the Nitinol technologies in the U.S. market, and continues the advancement of Nitinol implants and instruments.  This is accomplished by BME developing new standards for manufacturing processes, adding to its surgeon advisory boards, and focusing on the education of our surgeon communities on the clinical benefits of the Nitinol technology.  Innovation and strategic partnerships will further define the role of BME as leaders as demonstrated in our commitment to the BME surgeon and the patients.

SOURCE BME, Inc.

Related Links

http://www.bme-tx.com